Skip to content

Effectiveness of single dose pre-emptive ketorolac versus dexamethasone on post-operative morphine consumption and pain score after lumbar laminectomy: A randomized controlled trial

Effectiveness of single dose pre-emptive ketorolac versus dexamethasone on post-operative morphine consumption and pain score after lumbar laminectomy: A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230810002
Enrollment
120
Registered
2023-08-10
Start date
2022-10-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative change of the lumbar spine can cause lumbar stenosis or lumbar nerve root compression. The Spine Patient Outcomes Research Trial (SPORT) reported that surgery has a better therapeutic effect than non-surgical treatment, both in the field of pain reduction and healthy function of organs. Conventional lumbar laminectomy usually involves the extensive dissection of soft tissue, ligament, and bone, typically bringing on moderate to severe pain, especially in the first few days after t

Interventions

Ketorolac 30mg iv before induction phase of general anesthesia ,Dexamethasone 8mg iv before induction phase of general anesthesia
Experimental Drug,Active Comparator Drug
Ketorolac,Dexamethasone

Sponsors

Self
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 year-old 2. Scheduled elective lumbar spine decompressive laminectomy not more than 3 levels 3 .ASA physical status of between I and III

Exclusion criteria

Exclusion criteria: -Known allergy to ketorolac, acetaminophen, dexamethasone or morphine -History of previous lumbar surgery -History of renal impairment(creatinine clearance <30mm/min) -Opioid drug abuse -Current chronic anticoagulant or antiplatelet therapy -Contraindication to general anesthesia and inability to give informed consent -Poor control diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Measure assessed amount of morphine consumed. at PACU,12,24 and 48hour after surgery morphine comsumed measure by IV PCA( mg )

Secondary

MeasureTime frame
Measure assessed pain score. at PACU,12,24 and 48hour after surgery VAS (0-10 scores)

Countries

Thailand

Contacts

Public ContactTerdsak Phonchan

Khonkaen University

terdsak_p@kkumail.com0953189057

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026